AKT1 and breast cancer: The bitransgenic MMTV-c-ErbB2, MMTV-myr-Akt1 mice developed single focal mammary tumours with a mean latency of 114 days, meaning the bitransgenic animals develop mammary tumours twice as fast as the MMTV-c-ErbB2 mice (Figure 1a).